Virtual reality meets mindfulness: a new way to calm chemotherapy's side effects?

NCT ID NCT07731477

Recruiting now Symptom relief Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether a virtual reality-based mindfulness program can reduce anxiety, fatigue, and sleep problems while improving comfort in women newly diagnosed with breast cancer who are about to start chemotherapy. Half of the 50 participants will use the VR mindfulness sessions alongside standard care, while the other half receive standard care alone. Researchers will measure changes in anxiety, comfort, sleep quality, and fatigue using validated questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a virtual reality-based mindfulness intervention
What this could lead to: If it works, this could offer a drug-free way to help breast cancer patients manage anxiety, fatigue, and sleep issues during chemotherapy.
What could go wrong: This is a small early-stage trial with only 50 participants, so results may not apply broadly. The intervention requires a VR headset and guided sessions, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CHEMOTHERAPY

Contacts and locations

Locations

Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital, Ministry of Health, Republic of Turkey
RECRUITING

Ankara, Ankara, 06830, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.